Francesco Vetri
Pain Medicine · Decatur, ILNPI 1427323864
Payments from drug & device makers
Across 483 payments — averaging $166.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- SPR Therapeutics, Inc$49K
- Avanos Medical$12K
- Tersera Therapeutics LLC$5K
- Medtronic$4K
- Averitas Pharma Inc.$3K
- Nevro Corp.$968
- plus $7K from 31 others
What the payments were for
- Consulting fees$4,53626%
- Travel & lodging$2,00011%
- Food & beverage$10,96963%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| SPR Therapeutics, Inc | 11 | $48,837 |
| Avanos Medical | 5 | $11,952 |
| Tersera Therapeutics LLC | 22 | $5,312 |
| Medtronic(2 entities) | 66 | $3,661 |
| Averitas Pharma Inc. | 3 | $2,523 |
| Nevro Corp. | 19 | $968 |
| Relievant Medsystems, Inc. | 8 | $962 |
| AbbVie(2 entities) | 61 | $940 |
| Abbott | 50 | $722 |
| Teva Pharmaceuticals USA, Inc. | 47 | $627 |
| Painteq LLC | 8 | $518 |
| Boston Scientific | 11 | $415 |
| Pfizer | 22 | $371 |
| Lundbeck LLC | 16 | $367 |
| Lilly USA, LLC | 20 | $336 |
| Biodelivery Sciences International, Inc. | 17 | $311 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 22 | $295 |
| Biohaven Pharmaceutical Holding Company Ltd. | 13 | $225 |
| Stryker | 1 | $169 |
| Collegium Pharmaceutical, Inc. | 14 | $169 |
| Novartis | 11 | $152 |
| Amgen | 9 | $138 |
| Vertos Medical, Inc. | 1 | $100 |
| Arbor Pharmaceuticals, Inc. | 5 | $77 |
| Radius Health, Inc. | 4 | $61 |
| Biohaven Pharmaceuticals, Inc. | 3 | $47 |
| MDD US Operations, LLC | 2 | $32 |
| Assertio Therapeutics, Inc. | 2 | $27 |
| Shionogi Inc | 2 | $24 |
| GRT US Holding, Inc. | 1 | $24 |
| Vertex | 1 | $19 |
| Si-bone, Inc. | 1 | $18 |
| Foundation Fusion Solutions, LLC | 1 | $18 |
| Redhill Biopharma Inc. | 1 | $16 |
| Almatica Pharma LLC | 1 | $15 |
| Vertiflex, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PRIALT$4,847
- Intracept$1,814
- INTELLIS ADAPTIVESTIM$1,671
- PAINTEQ$430
- INTELLIS$339
- VANTA ADAPTIVESTIM$200
- IVS - VERTEBRAL AUGMENTATION PRODUCTS$169
- FUSION$159
- SUPERION$148
- Omnia$133
- AJOVY$125
- Senza$117
- Senza Spinal Cord Stimulation System$115
- mild Device Kit$100
How this compares
$80,479 in reported general payments places this provider in the 95th percentile of 233 pain medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NucyntaTapentadol Hcl | 23 | $36,784 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 737 | $22,234 |
| MovantikNaloxegol Oxalate | 45 | $19,156 |
| Buprenorphine | 49 | $16,462 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 329 | $11,332 |
| SymproicNaldemedine Tosylate | 20 | $8,863 |
| BelbucaBuprenorphine Hcl | 19 | $8,344 |
| Lidocaine | 32 | $5,221 |
| Xtampza ErOxycodone Myristate | 12 | $4,835 |
| Pregabalin | 201 | $3,646 |
| Gabapentin | 172 | $3,275 |
| Fentanyl | 26 | $2,634 |
| Tizanidine Hcl | 287 | $2,491 |
| Morphine Sulfate ErMorphine Sulfate | 94 | $2,198 |
| Morphine Sulfate | 76 | $2,074 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta, Belbuca, Xtampza Er | $169 | $49,96354 claims |
| Redhill Biopharma Inc.Movantik | $16 | $19,15645 claims |
| Shionogi IncSymproic | $24 | $8,86320 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 233 pain medicine providers in Illinois.
Other pain medicine in Decatur
- Ricardo VallejoBloomington$3.1M
- David DickersonEvanston$766K
- Albert SinghQuincy$357K
- Steven CohenChicago$292K
- Thomas DahlbergRockford$218K
- Nirav ShahSkokie$137K
- Ryan KutaNaperville$114K
- Anthony LebarioElgin$87K
- Keith SchmidtHoffman Estates$81K
- Goran TubicBolingbrook$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.